Friday 6 November 2026 Export COR’s income statement to Excel — free account

Cencora, Inc.

Cencora, Inc.’s revenue for fiscal 2026 (year ended September 2026) was $337.4 billion, up 5.00% from fiscal 2025.

Revenue: +5.52%
EPS: +258.4%
Free cash flow: −7.81%
Total debt: +47.1%

Quarter to September 2026, against a year earlier

334.28 5.40 −1.59%

Follow COR

Alert me

Market cap: $64.8B
P/E: 18.8×
Fwd P/E: 17.5×
Dividend yield: 0.71%
F-score: 7/9
Altman Z: n/a
Beneish M: −2.59
Dividend safety: 70/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Cencora, Inc. (COR) revenue by segment, product and region

	Q4 FY2025	Q3 FY2025	Q2 FY2025	Q1 FY2025	Q4 FY2024	Q3 FY2024	Q2 FY2024	Q1 FY2024	Q4 FY2023	Q3 FY2023	Q2 FY2023	Q1 FY2023
U.S. Healthcare Solutions	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
International Healthcare Solutions	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Pharmaceutical Distribution	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
MWI Animal Health	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Global Commercialization Services	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Intersegment Eliminations	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Other Segments	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Revenue	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡

As each company reports them in its 10-K and 10-Q filings, in US dollars. Where a later filing recast a year's segments, the year is shown as recast; a period whose breakdown does not add up to the company's revenue is left out.

Cencora, Inc. (COR) revenue by segment, product and region

Stockrow Weekly